BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 17464266)

  • 21. Performance characteristics obtained for a new 3-dimensional lutetium oxyorthosilicate-based whole-body PET/CT scanner with the National Electrical Manufacturers Association NU 2-2001 standard.
    Brambilla M; Secco C; Dominietto M; Matheoud R; Sacchetti G; Inglese E
    J Nucl Med; 2005 Dec; 46(12):2083-91. PubMed ID: 16330574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dual modality approach to quantitative quality control in emission tomography.
    Thomas MD; Bailey DL; Livieratos L
    Phys Med Biol; 2005 Aug; 50(15):N187-94. PubMed ID: 16030376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity and daily quality control of a mobile PET/CT scanner operating in 3-dimensional mode.
    Belakhlef A; Church C; Fraser R; Lakhanpal S
    J Nucl Med Technol; 2007 Dec; 35(4):229-31. PubMed ID: 18006593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
    Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG
    J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities.
    Surti S; Kuhn A; Werner ME; Perkins AE; Kolthammer J; Karp JS
    J Nucl Med; 2007 Mar; 48(3):471-80. PubMed ID: 17332626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction methods for random coincidences in fully 3D whole-body PET: impact on data and image quality.
    Brasse D; Kinahan PE; Lartizien C; Comtat C; Casey M; Michel C
    J Nucl Med; 2005 May; 46(5):859-67. PubMed ID: 15872361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving 3D PET imaging by restoration: a phantom study.
    Knesaurek K; Machac J
    Comput Med Imaging Graph; 2005 Jan; 29(1):15-9. PubMed ID: 15710537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers.
    Breen SL; Publicover J; De Silva S; Pond G; Brock K; O'Sullivan B; Cummings B; Dawson L; Keller A; Kim J; Ringash J; Yu E; Hendler A; Waldron J
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):763-70. PubMed ID: 17379435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Flying through" and "flying around" a PET/CT scan: Pilot study and development of 3D integrated 18F-FDG PET/CT for virtual bronchoscopy and colonoscopy.
    Quon A; Napel S; Beaulieu CF; Gambhir SS
    J Nucl Med; 2006 Jul; 47(7):1081-7. PubMed ID: 16818940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation correction of four dimensional (4D) PET using phase-correlated 4D-computed tomography.
    Pönisch F; Richter C; Just U; Enghardt W
    Phys Med Biol; 2008 Jul; 53(13):N259-68. PubMed ID: 18562779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phantom study of the impact of reconstruction parameters on the detection of mini- and micro-volume lesions with a low-dose PET/CT acquisition protocol.
    Ferretti A; Bellan E; Gava M; Chondrogiannis S; Massaro A; Nibale O; Rubello D
    Eur J Radiol; 2012 Nov; 81(11):3363-70. PubMed ID: 22613508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of 2D versus 3D whole-body PET image quality using a dedicated BGO PET scanner.
    Visvikis D; Griffiths D; Costa DC; Bomanji J; Ell PJ
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1050-6. PubMed ID: 15846487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Explicit incorporation of prior anatomical information into a nonrigid registration of thoracic and abdominal CT and 18-FDG whole-body emission PET images.
    Camara O; Delso G; Colliot O; Moreno-Ingelmo A; Bloch I
    IEEE Trans Med Imaging; 2007 Feb; 26(2):164-78. PubMed ID: 17304731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner.
    Lodge MA; Badawi RD; Gilbert R; Dibos PE; Line BR
    J Nucl Med; 2006 Jan; 47(1):23-31. PubMed ID: 16391183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of standardized uptake values obtained from two- and three-dimensional modes of fluorine-18 fluorodeoxyglucose PET-CT in oncological cases.
    Kocabaş B; Yapar AF; Reyhan M; Aktaş A; Aydin M; Gençoğlu EA
    Diagn Interv Radiol; 2013; 19(2):126-9. PubMed ID: 23266970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system.
    Okubo M; Nishimura Y; Nakamatsu K; Okumura M; Shibata T; Kanamori S; Hanaoka K; Hosono M
    Ann Nucl Med; 2008 Aug; 22(7):579-86. PubMed ID: 18756360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
    Drzezga A; Souvatzoglou M; Eiber M; Beer AJ; Fürst S; Martinez-Möller A; Nekolla SG; Ziegler S; Ganter C; Rummeny EJ; Schwaiger M
    J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of the injected activity in dynamic 3D PET: a generalized approach using patient-specific NECs as demonstrated by a series of 15O-H2O scans.
    Walker MD; Matthews JC; Asselin MC; Saleem A; Dickinson C; Charnley N; Julyan PJ; Price PM; Jones T
    J Nucl Med; 2009 Sep; 50(9):1409-17. PubMed ID: 19690021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.